REBOA in Trauma: A Life-Saving Procedure Explained
"Understanding the Role of REBOA in Severe Trauma and Its Impact on Patient Outcomes"
In the high-stakes world of trauma care, where every second counts, medical professionals are constantly seeking innovative ways to save lives. One such advancement is the Resuscitative Endovascular Balloon Occlusion of the Aorta, or REBOA. This procedure involves temporarily blocking the aorta, the body's main artery, to control bleeding and improve blood flow to vital organs. While it's a complex intervention, understanding REBOA is crucial for anyone interested in the cutting edge of emergency medicine.
REBOA has emerged as a vital tool for managing patients with severe torso trauma, particularly those experiencing life-threatening bleeding. This article delves into the intricacies of REBOA, exploring its uses, benefits, and potential risks. We'll also examine the latest research, providing a comprehensive understanding of how this procedure is revolutionizing trauma management.
For many, the term 'trauma' might evoke images of car accidents, falls, or gunshot wounds. In such critical situations, rapid intervention is essential. REBOA provides a crucial bridge, allowing medical teams to stabilize patients and control bleeding while preparing for definitive surgical interventions. This approach has shown promising results, significantly improving patient outcomes in the most challenging circumstances.
Current Use and Evidence
REBOA use remains controversial, with limited data on patient selection and outcomes in severe non-compressible torso trauma. A nationwide emergency-department study published in December 2024 examined trends in its use. Research also reports that surgical and non-surgical medical disciplines can perform REBOA successfully to an almost equal extent, while external landmarks and palpation are often used for common femoral artery access.
Approach and Limitations
REBOA is generally understood as a temporary hemorrhage-control measure used during resuscitation of critically injured patients. Its application requires careful patient selection, vascular access, balloon placement, and coordination with definitive hemorrhage control. Because the procedure can be technically demanding and its evidence base remains limited, practice may vary by institution, specialty, and available training.
From Balloon Tamponade to REBOA
REBOA was first described in the 1950s, when early attempts faced several technical challenges. Hughes C. W. reported intra-aortic balloon catheter tamponade for controlling intra-abdominal hemorrhage in humans in a 1954 Surgery article. Later advances in endovascular technology renewed interest in REBOA as a less invasive alternative to resuscitative thoracotomy with aortic cross-clamping.
What is REBOA? A Detailed Explanation
REBOA is a minimally invasive procedure where a balloon catheter is inserted into the aorta through a small incision, typically in the leg. The catheter is guided to the appropriate location in the aorta, and the balloon is inflated to temporarily block blood flow. This controlled blockage serves several critical purposes in trauma care. REBOA is generally divided into two zones to define where in the aorta the balloon is placed, allowing medical professionals to tailor the procedure to the patient's specific needs.
- Zone 1 REBOA: The balloon is inflated above the celiac artery, stopping the blood flow to the abdomen and pelvis.
- Zone 3 REBOA: The balloon is inflated below the renal arteries, restricting blood flow to the pelvis and lower extremities.
- Partial REBOA (P-REBOA): This method involves partial occlusion of the aorta.
Evidence Still Evolving
Recent reviews continue to describe REBOA's clinical efficacy and optimal use as subjects of ongoing debate. A 2025 committee review conditionally recommended against REBOA for hemodynamically unstable trauma patients with suspected subdiaphragmatic hemorrhage because of associated risks and a lack of discernible benefit. The same review called for further research to identify specific subgroups that may benefit, while a separate review examined REBOA's efficacy, safety, applications, and limitations in postpartum hemorrhage.
Risks and Uncertainty
REBOA is not universally successful and may expose patients to serious complications, particularly when patient selection, timing, access, or balloon management is suboptimal. Its temporary occlusion does not replace definitive control of bleeding, and prolonged or poorly coordinated use may create additional physiological risks. These limitations help explain why current recommendations remain cautious and why the procedure continues to require further study.
REBOA Compared With Alternatives
Comparative studies examine REBOA against resuscitative thoracotomy and standard care without REBOA, focusing on in-hospital mortality and indicators of treatment success. A 2025 meta-analysis likewise compared survival, side effects, and applications of REBOA and resuscitative thoracotomy for non-compressible truncal hemorrhage. Hardware comparisons also describe a newer, smaller REBOA catheter alongside a more commonly used device, highlighting that the comparison involves both treatment strategies and equipment.
The Future of Trauma Care: REBOA and Beyond
REBOA represents a significant advancement in trauma care, offering a life-saving solution for patients with severe bleeding. As technology continues to evolve and medical teams gain more experience, REBOA's role in emergency medicine will only grow. However, continuous research, careful patient selection, and meticulous execution are essential to maximize the benefits and minimize the risks associated with this procedure. As we move forward, REBOA remains a powerful tool in the fight to save lives and improve outcomes for those facing the most critical injuries.
A Conditional Role
A systematic review and meta-analysis found no mortality benefit for REBOA over no REBOA in hemodynamically unstable trauma patients with suspected subdiaphragmatic bleeding. The review notes that REBOA can be safe and effective with appropriate training, but its indications remain debated. Taken together, the evidence supports viewing REBOA as a carefully selected, temporary intervention rather than a universally beneficial replacement for established hemorrhage-control strategies.
Where Research Must Go
Future work will need to clarify which trauma patients benefit from REBOA, when it should be deployed, and how balloon occlusion can be managed most safely. Research should also address the procedure's complications, implementation requirements, and differences between patient populations. Better evidence may help resolve the current uncertainty over optimal use and identify specific subgroups for whom REBOA offers meaningful benefit.
Teamwork and Complications
REBOA creates systemic challenges that extend beyond catheter placement. Distal embolization and lower-limb ischemia are reported as the most prevalent procedure-related complications, with an incidence of 16% and a range of 4% to 52.6%. Balloon deflation also requires a coordinated team response, with communication between the surgeon and anesthesiologist needed to time blood products and adjunctive medications.
Speed, Experience, and Evidence
In a real-world case series of seven REBOA maneuvers, establishment time ranged from 7 to 40 minutes. The report emphasizes fast decision-making and experience with vascular-access strategies, and recommends keeping REBOA materials available in emergency rooms. At the same time, human evidence remains limited and conflicting, comprising case series, retrospective and prospective cohort studies, and reviews with divergent results.